4 weeks Rhythm Pharmaceuticals’ (RYTM) Buy Rating Reiterated at HC WainwrightMarketBeat
HC Wainwright restated a “buy” rating and set a $64.00 target price on shares of Rhythm Pharmaceuticals in a report on Friday.
XHC Wainwright restated a “buy” rating and set a $64.00 target price on shares of Rhythm Pharmaceuticals in a report on Friday.
X